HOME         WEBSITE         SUBSCRIBE           E-GREETINGS   
                               

Friday, November 23, 2012

New India to hike health cover rates

New India Assurance Company, the country’s largest non-life insurer, will be increasing the premium rates for its health insurance product. The insurer has filed a revised version of its health insurance policy with an increase in premium rates. G Srinivasan, chairman and managing director, New India, while announcing the company’s financial results for the first half of the year, said, “Last revision in health insurance premium rates was in 2007.    

In the past five years, we have not increased the premium on our health insurance product despite medical costs rising by 8-10 per cent annually. Therefore, we have recently filed for revision in the health insurance premium rates with the insurance regulator and are hopeful to launch the (revised health insurance) product soon.” Srinivasan refused to give details on the amount of revision and the change in the features of the product that will be launched. The insurance company has been able to curtail the loss ratio in the health insurance business to 88 per cent in the first half of the current financial year, from 104 per cent in the same period last year.

The firm is targeting to lower the loss ratio in its health portfolio to 80 per cent by the end of this financial year. However, the loss ratios in motor and fire business are rising. New India Assurance controls around 15 per cent of the insurance market. Speaking about the plans of the public sector insurers to have a common third-party agent (TPA) company, Srinivasan said, that besides New India Assurance, the other three other general insurers – Oriental Insurance, National Insurance, United India Insurance, domestic reinsurer General Insurance Corporation and public sector behemoth Life Insurance Corporation will have a stake in the company. “The common TPA company will be launched in four to six months time,” said Srinivasan.

For the first half of FY13 ended September 30, New India reported a 216 per cent rise in net profit at Rs 205.08 crore, compared with a net profit of Rs 95 crore in the same period of FY12. The net profit resulted from profits in its investment income as the company registered an underwriting loss of Rs 1,122 crore for the first half of the FY13, compared with an underwriting loss of Rs 1,069 crore in the same period last year. For the first half of FY13, its domestic business grew at 15 per cent to almost Rs 5,000 crore and foreign operations saw a growth of 34.14 pr cent.

The growth in domestic business came largely from selling retail covers (selling health and motor policies). The insurance company is targeting to open 300 new offices in the country, of which, it has already opened 264 offices.
Posted by

Blog Archive

____________________________________________________________________________________________

Disclaimer - All investments in Mutual Funds and securities are subject to market risks and uncertainty of dividend distributions and the NAV of schemes may go up or down depending upon factors and forces affecting securities markets generally. The past performance of the schemes is not necessarily indicative of the future performance and may not necessarily provide a basis for comparison with other investments. Investors are advised to go through the respective offer documents before making any investment decisions. Prospective client(s) are advised to go through all comparable products in offer before taking any investment decisions. Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the fund will be achieved. Information gathered & material used in this document is believed to be from reliable sources. Decisions based on the information provided on this newsletter/document are for your own account and risk.


In the preparation of the material contained in this document, Varun Vaid has used information that is publicly available, including information developed in-house. Some of the material used in the document may have been obtained from members/persons other than the Varun Vaid and which may have been made available to Varun Vaid. Information gathered & material used in this document is believed to be from reliable sources. Varun Vaid however does not warrant the accuracy, reasonableness and/or completeness of any information. For data reference to any third party in this material no such party will assume any liability for the same. Varun Vaid does not in any way through this material solicit any offer for purchase, sale or any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice.


Varun Vaid, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of this material in any manner. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. All recipients of this material should before dealing and/or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investigating in any product/financial instruments should do soon the basis of and after verifying the terms attached to such product/financial instrument. Financial products and instruments are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products and instruments does not necessarily indicate the future prospects and performance there of. Such past performance may or may not be sustained in future. Varun Vaid, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial instruments/products/commodities discussed here in or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The said person may have acted upon and/or in a manner contradictory with the information contained here. No part of this material may be duplicated in whole or in part in any form and or redistributed without the prior written consent of Varun Vaid. This material is strictly confidential to the recipient and should not be reproduced or disseminated to anyone else.


Varun Vaid also does not take any responsibility for the contents of the advertisements published. Readers are advised to verify the contents on their own before acting there upon.


Published Credits goes to following sources & all the mentioned sources as footer below the published material- Bloomberg, Valueresearch Online, Capital Market, Navindia, Franklin Templeton, Kitco, SBI AMC, LIC AMC, JM Financial AMC, HDFC AMC, The Hindu, Business Line, Personal FN, Economic Times, Reuters, Outlook Money, Business Standard, Times of India etc.